Tepotinib in patients with advanced non-small lung cancer (NSCLC) and MET exon 14-skipping mutations: Phase II data Meeting Abstract


Authors: Sakai, H.; Felip, E.; Cortot, A. B.; Veillon, R.; Griesinger, F.; Patel, J.; Horn, L.; Mazieres, J.; De Castro Carpeno, J.; Morise, M.; Sakamoto, T.; Bruns, R.; Scheele, J.; Straub, J.; Paik, P.
Abstract Title: Tepotinib in patients with advanced non-small lung cancer (NSCLC) and MET exon 14-skipping mutations: Phase II data
Meeting Title: ESMO Asia Congress 2018
Journal Title: Annals of Oncology
Volume: 29
Issue: Suppl. 9
Meeting Dates: 2018 Nov 23-25
Meeting Location: Singapore
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2018-11-01
Start Page: mdy425.004
Language: English
ACCESSION: WOS:000458082200005
PROVIDER: wos
DOI: 10.1093/annonc/mdy425.004
Notes: Meeting Abstract: 493O -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Paul K Paik
    237 Paik